- Home
- ESPR vs BSL Comparison
ESPR vs BSL Comparison
Compare ESPR & BSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- BSL
- Stock Information
- Founded
- ESPR 2008
- BSL 2010
- Country
- ESPR United States
- BSL United States
- Employees
- ESPR N/A
- BSL N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- BSL Trusts Except Educational Religious and Charitable
- Sector
- ESPR Health Care
- BSL Finance
- Exchange
- ESPR Nasdaq
- BSL Nasdaq
- Market Cap
- ESPR 220.0M
- BSL 183.2M
- IPO Year
- ESPR 2013
- BSL N/A
- Fundamental
- Price
- ESPR $1.40
- BSL $14.16
- Analyst Decision
- ESPR Buy
- BSL
- Analyst Count
- ESPR 6
- BSL 0
- Target Price
- ESPR $6.50
- BSL N/A
- AVG Volume (30 Days)
- ESPR 5.1M
- BSL 71.9K
- Earning Date
- ESPR 08-05-2025
- BSL 01-01-0001
- Dividend Yield
- ESPR N/A
- BSL 9.55%
- EPS Growth
- ESPR N/A
- BSL N/A
- EPS
- ESPR N/A
- BSL N/A
- Revenue
- ESPR $259,574,000.00
- BSL N/A
- Revenue This Year
- ESPR $6.10
- BSL N/A
- Revenue Next Year
- ESPR N/A
- BSL N/A
- P/E Ratio
- ESPR N/A
- BSL N/A
- Revenue Growth
- ESPR 12.99
- BSL N/A
- 52 Week Low
- ESPR $0.69
- BSL $12.19
- 52 Week High
- ESPR $3.94
- BSL $14.56
- Technical
- Relative Strength Index (RSI)
- ESPR 58.85
- BSL 44.70
- Support Level
- ESPR $1.13
- BSL $14.05
- Resistance Level
- ESPR $1.74
- BSL $14.31
- Average True Range (ATR)
- ESPR 0.17
- BSL 0.11
- MACD
- ESPR 0.01
- BSL -0.02
- Stochastic Oscillator
- ESPR 30.61
- BSL 36.67
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About BSL Blackstone
Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It also invests in second-lien loans and high yield bonds and employs financial leverage which may increase the risk to the Fund.